4//SEC Filing
Mei Baisong 4
Accession 0001415889-23-011382
CIK 0001650664other
Filed
Jul 20, 8:00 PM ET
Accepted
Jul 21, 4:30 PM ET
Size
4.9 KB
Accession
0001415889-23-011382
Insider Transaction Report
Form 4
Mei Baisong
SVP, CHIEF MEDICAL OFFICER
Transactions
- Sale
Common Stock
2023-07-19$8.80/sh−4,317$37,990→ 72,055 total
Footnotes (1)
- [F1]Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 14, 2022 and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on July 18, 2023. The sale does not represent a discretionary trade by the Reporting Person.
Documents
Issuer
Editas Medicine, Inc.
CIK 0001650664
Entity typeother
Related Parties
1- filerCIK 0001938499
Filing Metadata
- Form type
- 4
- Filed
- Jul 20, 8:00 PM ET
- Accepted
- Jul 21, 4:30 PM ET
- Size
- 4.9 KB